Literature DB >> 16773289

The healing of colon anastomosis covered with fibrin glue after early postoperative intraperitoneal chemotherapy.

I Kanellos1, E Christoforidis, D Kanellos, M G Pramateftakis, L Sakkas, D Betsis.   

Abstract

BACKGROUND: After colon resection for colonic cancer, the administration of antineoplastic agents may prolong survival by killing residual cancer calls and preventing metastasis, but may also slow anastomotic healing. This study was designed to determine the effects of 5-fluorouracil (5-FU) and leucovorin (LEV), injected intraperitoneally, on the healing of colonic anastomoses with or without fibrin glue (FG) covering.
METHODS: Sixty rats were randomized to one of four groups. After resection of a transverse colon segment, an end-to-end sutured anastomosis was performed. Rats in the 5-FU+LEV and the 5- FU+LEV+FG groups received 5-FU+LEV intraperitoneally. The colonic anastomoses of the rats in the FG group and in the 5-FU+LEV+FG group were covered with fibrin glue. All rats were killed on postoperative day 8. Bursting pressure measurements were recorded and the anastomoses were examined macroscopically and histologically.
RESULTS: The leakage rate of the anastomoses was significantly different among groups. Specifically, the leakage rate was significantly higher in the 5-FU+LEV group (40%) than in the FG and in the 5-FU+LEV+FG groups where there were no leakages (p=0.017). The mean adhesion formation score was significantly higher in rats of the 5-FU+LEV group, compared to the control (p=0.023), the FG (p=0.006) and the 5-FU+LEV+FG (p=0.006) groups. Bursting pressures were significantly lower in the 5-FU+LEV group than in the other groups (p<0.001). Also, bursting pressures were significantly lower in the control group compared to the FG and 5-FU+LEV+FG groups (p<0.001). Rats in the 5-FU+LEV+FG group had significantly greater neoangiogenesis and fibroblast activity than those in the 5-FU+LEV group (p=0.025).
CONCLUSION: The early intraperitoneal postoperative administration of 5-fluorouracil plus leucovorin impaired colonic wound healing. However, the application of fibrin glue prevented the deleterious effect of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773289     DOI: 10.1007/s10151-006-0263-4

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  5 in total

Review 1.  External coating of colonic anastomoses: a systematic review.

Authors:  Hans-Christian Pommergaard; Michael Patrick Achiam; Jacob Rosenberg
Journal:  Int J Colorectal Dis       Date:  2012-08-21       Impact factor: 2.571

2.  The prevention of colorectal anastomotic leakage with tissue adhesives in a contaminated environment is associated with the presence of anti-inflammatory macrophages.

Authors:  Zhouqiao Wu; Konstantinos A Vakalopoulos; Geesien S A Boersema; Leonard F Kroese; King H Lam; Paul H van der Horst; Irene M Mulder; Yvonne M Bastiaansen-Jenniskens; Gert-Jan Kleinrensink; Johannes Jeekel; Johan F Lange
Journal:  Int J Colorectal Dis       Date:  2014-09-26       Impact factor: 2.571

3.  Fibrinogen and thrombin concentrations are critical for fibrin glue adherence in rat high-risk colon anastomoses.

Authors:  Eliseo Portilla-de Buen; Abel Orozco-Mosqueda; Caridad Leal-Cortés; Gonzalo Vázquez-Camacho; Clotilde Fuentes-Orozco; Andrea Socorro Alvarez-Villaseñor; Michel Dassaejv Macías-Amezcua; Alejandro González-Ojeda
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

4.  Sustained-released mixture of vascular endothelial growth factor 165 and fibrin glue strengthens healing of ileal anastomoses in a rabbit model with intraperitoneal infection.

Authors:  Zhanwu Li; Wenjun Wang; Xiaozhou Wang; Lei Jiang; Fengyi Wang; Qiang Liu
Journal:  Ann Surg Treat Res       Date:  2017-08-30       Impact factor: 1.859

Review 5.  Our 20-year experience with experimental colonic anastomotic healing.

Authors:  Dimitrios Raptis; Manousos-Georgios Pramateftakis; Ioannis Kanellos
Journal:  J Med Life       Date:  2018 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.